Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial

This publication has 24 references indexed in Scilit:

• Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy
  Clinical Infectious Diseases, 2004
• Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis
  Antimicrobial Agents and Chemotherapy, 2004
• Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects
  Antimicrobial Agents and Chemotherapy, 2004
• Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus Infection in Mice: Comparative Studies in Two Laboratories
  Antimicrobial Agents and Chemotherapy, 2004
• Experimental Pulmonary Aspergillosis Due toAspergillus terreus:Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B
  The Journal of Infectious Diseases, 2003
• Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole
  Current Medical Research and Opinion, 2003
• Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
  Clinical Infectious Diseases, 2002
• Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
  Clinical Infectious Diseases, 2002
• Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
  Medicine, 2000
• Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and Review
  Clinical Infectious Diseases, 1992